KALA BIO, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 8.63 million compared to USD 12.84 million a year ago. Basic loss per share from continuing operations was USD 3.18 compared to USD 7.97 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.9 USD | +2.79% | -1.53% | -1.43% |
04-02 | HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating | MT |
03-29 | KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.43% | 19.43M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- KALA Stock
- News KALA BIO, Inc.
- KALA BIO, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023